English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: One of the possible explanations for clinical adverse reactions Journal article
Li, Xiaocui, Ou, Xiaowen, Ni, Jiadong, Xu, Yihong, Zuo, Huilin, Fu, Yu, Yang, Caihua, Zhao, Zhongxiang, Li, Na, Zhou, Hua, Zhang, Rong, Liu, Zhongqiu, Fu, Ling, Zhu, Lijun. Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: One of the possible explanations for clinical adverse reactions[J]. Toxicology and Applied Pharmacology, 2022, 445.
Authors:  Li, Xiaocui;  Ou, Xiaowen;  Ni, Jiadong;  Xu, Yihong;  Zuo, Huilin; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.3/3.6 | Submit date：2023/01/30
Adverse Reaction  Bulleyaconitine a  Cytochrome P450 Enzymes  Drug-drug Interactions  Human Liver Microsomes  Metabolism  
Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer Journal article
Zhao, Chengwei, Cao, Weilan, Zheng, Hailun, Xiao, Zhongxiang, Hhu, Jie, Yang, Lehe, Chen, Min, Liang, Guang, Zheng, Suqing, Zhao, chengguang. Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer[J]. International Journal of Nanomedicine, 2019, 14, 1597-1618.
Authors:  Zhao, Chengwei;  Cao, Weilan;  Zheng, Hailun;  Xiao, Zhongxiang;  Hhu, Jie; et al.
Favorite | TC[WOS]:24 TC[Scopus]:25 | Submit date：2022/05/23
Cinnamaldehyde  Colon Cancer  Hydroxy Camptothecin  Ph-responsive Nanoparticles  Ros